Routine compliance certificate on share dematerialization for Q2 FY2027

Compliance View source PDF Explain this filing

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.8%Reaction day

₹1550.00

prior close

₹1511.50

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.4%-3.2% vs market

Pharmaceuticals peers, median of 173sector-0.7%-2.2% vs sector

On the reaction day the stock moved 3.2 pts less than Nifty Smallcap 250 and 2.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.5

15m

+0.5

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.8+0.4-3.2-0.7-2.2

Next day

+0.9+1.8-0.9+0.6+0.3

+0.4+1.9-1.5+0.3+0.0

-2.5-0.6-1.9-2.3-0.2

-4.1-0.1-4.0-2.1-2.0

-4.9+1.0-5.9-2.5-2.4

-7.7+1.4-9.1-2.4-5.3

15d

-4.2pendingpending-4.4+0.3

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sai Life Sciences submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. Its registrar KFin Technologies confirmed that details of securities dematerialized and rematerialized during the quarter have been furnished to NSE and BSE. The filing is procedural with no change in share structure.

Likely market impact

No impact on shareholders or stock price. This is a routine quarterly compliance requirement with no material information.